ZA919772B - Heterocyclic compounds - Google Patents

Heterocyclic compounds

Info

Publication number
ZA919772B
ZA919772B ZA919772A ZA919772A ZA919772B ZA 919772 B ZA919772 B ZA 919772B ZA 919772 A ZA919772 A ZA 919772A ZA 919772 A ZA919772 A ZA 919772A ZA 919772 B ZA919772 B ZA 919772B
Authority
ZA
South Africa
Prior art keywords
heterocyclic compounds
heterocyclic
compounds
Prior art date
Application number
ZA919772A
Other languages
English (en)
Inventor
Martin Paul Edwards
Paul Edwards Martin
John David Sherwood
David Sherwood John
Original Assignee
Ici Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ici Plc filed Critical Ici Plc
Publication of ZA919772B publication Critical patent/ZA919772B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/10Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D209/24Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with an alkyl or cycloalkyl radical attached to the ring nitrogen atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA919772A 1990-12-12 1991-12-11 Heterocyclic compounds ZA919772B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB909027018A GB9027018D0 (en) 1990-12-12 1990-12-12 Heterocyclic compounds

Publications (1)

Publication Number Publication Date
ZA919772B true ZA919772B (en) 1992-09-30

Family

ID=10686919

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA919772A ZA919772B (en) 1990-12-12 1991-12-11 Heterocyclic compounds

Country Status (28)

Country Link
US (1) US5294636A (fi)
EP (1) EP0490649B1 (fi)
JP (1) JP2650807B2 (fi)
KR (1) KR100194479B1 (fi)
CN (2) CN1032469C (fi)
AP (1) AP286A (fi)
AT (1) ATE145199T1 (fi)
AU (1) AU656344B2 (fi)
CA (1) CA2056067C (fi)
CZ (1) CZ288151B6 (fi)
DE (1) DE69123123T2 (fi)
DK (1) DK0490649T3 (fi)
ES (1) ES2094797T3 (fi)
FI (1) FI101296B1 (fi)
GB (2) GB9027018D0 (fi)
GR (1) GR3021605T3 (fi)
HK (1) HK81497A (fi)
HU (2) HU213109B (fi)
IE (1) IE914316A1 (fi)
IL (1) IL100090A (fi)
MX (1) MX9102475A (fi)
MY (1) MY108629A (fi)
NZ (1) NZ240940A (fi)
PH (1) PH30041A (fi)
RU (1) RU2107682C1 (fi)
SK (1) SK279018B6 (fi)
TW (1) TW222264B (fi)
ZA (1) ZA919772B (fi)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE113581T1 (de) * 1990-05-04 1994-11-15 Ciba Geigy Ag Substituierte indole.
IL100091A (en) * 1990-12-12 1998-08-16 Zeneca Ltd Pharmaceutical preparations containing the physical form of [4] 5) Cyclopentyloxycarbyl (amino 1 methyl indole 3 methyl methyl [3 methoxybenzoyl [2 methylbenzole)
GB9119001D0 (en) * 1991-09-05 1991-10-23 Ici Plc Pharmaceutical agents
GR1001368B (el) * 1992-10-08 1993-10-29 Ici Plc Φαρμακευτικοί φορείς.
DE4235133A1 (de) * 1992-10-19 1994-04-21 Bayer Ag Kristallines (R)-(-)-2-Cycloheptyl-N-methylsulfonyl-[4-(2-chinolinyl-methoxy)-phenyl]-acetamid
DK0721331T3 (da) * 1993-10-01 2002-02-11 Astrazeneca Ab Fremgangsmåde
IS1736B (is) 1993-10-01 1999-12-30 Astra Ab Aðferð og tæki sem stuðla að aukinni samloðun agna
GB9723985D0 (en) 1997-11-14 1998-01-14 Zeneca Ltd Pharmaceutical compositions
GB9726735D0 (en) * 1997-12-18 1998-02-18 Zeneca Ltd Pharmaceutical compositions
IL139243A0 (en) * 2000-10-24 2001-11-25 Internat Specialty Products Is Ethanolate of zafirlukast, process for manufacture and pharmaceutical compositions thereof
TWI353979B (en) * 2002-04-10 2011-12-11 Nippon Zoki Pharmaceutical Co Novel crystal form of 5-hydroxy-1-methylhydantoin
US20090317476A1 (en) * 2003-07-31 2009-12-24 Robinson Cynthia B Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a leukotriene receptor antagonist for treatment of asthma or chronic obstructive pulmonary disease
US20050026882A1 (en) * 2003-07-31 2005-02-03 Robinson Cynthia B. Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a leukotriene receptor antagonist for treatment of asthma or chronic obstructive pulmonary disease
US20050113410A1 (en) * 2003-11-03 2005-05-26 Mark Tawa Pharmaceutical salts of zafirlukast
US20080254114A1 (en) * 2005-03-03 2008-10-16 Elan Corporation Plc Controlled Release Compositions Comprising Heterocyclic Amide Derivative Nanoparticles
US20070197467A1 (en) * 2006-02-06 2007-08-23 Srinivasulu Rangineni Zafirlukast compositions
US20090012146A1 (en) * 2007-07-02 2009-01-08 Giridhar Reddy Buggana Solubility-enhanced pharmaceutical compositions comprising zafirlukast
WO2009018280A2 (en) * 2007-07-30 2009-02-05 Auspex Pharamaceuticals, Inc. Substituted indoles
TWI469965B (zh) * 2008-12-22 2015-01-21 Ono Pharmaceutical Co 乙炔基吲哚化合物
WO2014012954A1 (en) 2012-07-18 2014-01-23 Takeda Gmbh Treatment of partly controlled or uncontrolled severe asthma
CN103396353B (zh) * 2013-08-23 2015-05-20 海南通用三洋药业有限公司 一种扎鲁司特无定型态及其制备方法
WO2015110394A1 (en) 2014-01-22 2015-07-30 Takeda Gmbh Treatment of partly controlled or uncontrolled severe asthma with a pde4 inhibitor (and in combination with a leukotriene modifier)
PT109030B (pt) 2015-12-15 2019-09-25 Hovione Farmaciência, S.A. Preparação de partículas inaláveis de zafirlucaste
BR112019015721A2 (pt) 2017-01-30 2020-03-24 Western New England University Inibidores de tiol isomerases e uso dos mesmos
CN117999074A (zh) 2021-05-19 2024-05-07 奎尔塞斯制药股份公司 用于治疗肌萎缩侧索硬化症的含有槲皮素的组合物
WO2023214391A1 (en) 2022-05-06 2023-11-09 Quercis Pharma AG Method for treating cancers and neurological diseases using quercetin-containing compositions

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4161516A (en) * 1975-07-25 1979-07-17 Fisons Limited Composition for treating airway disease
GB8607294D0 (en) * 1985-04-17 1986-04-30 Ici America Inc Heterocyclic amide derivatives

Also Published As

Publication number Publication date
DE69123123D1 (de) 1996-12-19
AP9100341A0 (en) 1992-01-31
GB9027018D0 (en) 1991-01-30
GB9126353D0 (en) 1992-02-12
FI915825A (fi) 1992-06-13
NZ240940A (en) 1994-05-26
DE69123123T2 (de) 1997-03-06
KR920012031A (ko) 1992-07-25
FI101296B (fi) 1998-05-29
MX9102475A (es) 1992-06-01
CZ288151B6 (en) 2001-05-16
IL100090A (en) 1996-09-12
EP0490649B1 (en) 1996-11-13
MY108629A (en) 1996-10-31
IL100090A0 (en) 1992-08-18
JPH04266872A (ja) 1992-09-22
CN1148491A (zh) 1997-04-30
CN1074411C (zh) 2001-11-07
CA2056067C (en) 2001-09-04
AU8899591A (en) 1992-06-18
CS375891A3 (en) 1992-06-17
CN1032469C (zh) 1996-08-07
DK0490649T3 (da) 1997-04-21
ES2094797T3 (es) 1997-02-01
JP2650807B2 (ja) 1997-09-10
US5294636A (en) 1994-03-15
CN1063100A (zh) 1992-07-29
CA2056067A1 (en) 1992-06-13
AU656344B2 (en) 1995-02-02
RU2107682C1 (ru) 1998-03-27
AP286A (en) 1993-09-26
PH30041A (en) 1996-11-08
FI915825A0 (fi) 1991-12-11
EP0490649A1 (en) 1992-06-17
HUT60717A (en) 1992-10-28
GB2250743B (en) 1995-02-15
FI101296B1 (fi) 1998-05-29
HU211125A9 (en) 1995-10-30
TW222264B (fi) 1994-04-11
HU913863D0 (en) 1992-02-28
SK279018B6 (sk) 1998-05-06
GR3021605T3 (en) 1997-02-28
ATE145199T1 (de) 1996-11-15
HK81497A (en) 1997-06-27
GB2250743A (en) 1992-06-17
KR100194479B1 (ko) 1999-06-15
IE914316A1 (en) 1992-06-17
HU213109B (en) 1997-02-28

Similar Documents

Publication Publication Date Title
AP9100341A0 (en) Heterocyclic compounds
GB9010394D0 (en) Heterocyclic compounds
AP9100243A0 (en) Heterocyclic compounds
AP9100320A0 (en) Heterocyclic compounds
GB9020931D0 (en) Heterocyclic compounds
GB9020932D0 (en) Heterocyclic compounds
GB9022445D0 (en) Heterocyclic compounds
GB9022444D0 (en) Heterocyclic compounds
GB9003551D0 (en) Heterocyclic compounds
EP0442654A3 (en) Heterocyclic compounds
GB9003549D0 (en) Heterocyclic compounds
GB9003547D0 (en) Heterocyclic compounds
GB9016894D0 (en) Heterocyclic compounds
GB9001875D0 (en) Heterocyclic compounds
GB9026801D0 (en) Heterocyclic compounds
GB9026796D0 (en) Heterocyclic compounds
GB9015484D0 (en) Heterocyclic compounds
GB9003550D0 (en) Heterocyclic compounds
GB9026795D0 (en) Heterocyclic compounds
GB9003552D0 (en) Heterocyclic compounds
GB9022337D0 (en) Heterocyclic compounds
GB9003554D0 (en) Heterocyclic compounds
GB9026794D0 (en) Heterocyclic compounds
GB9016979D0 (en) Heterocyclic compounds
GB9026617D0 (en) Heterocyclic compounds